Introduction of a hypomorphic mutation of PDK1 in a PTEN cancer mouse model suppresses tumorigenesis [107], confirming the oncogenic role of PDK1 as one of the downstream effectors of the PI3K/PTEN signaling, and suggesting PDK1 as a promising anticancer target. The gene discussed is PIK3CA; the disease is cancer.